NCT03244449
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,680 public trials
156 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01754142
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Research Site Seoul, South Korea
NCT01575483
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Research Site Seoul, South Korea
NCT00494767
- Conditions
- Body Weight, Body Weight Changes, Diabetes Mellitus, +12 more
- Locations
-
- GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom
NCT00551564
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- GSK Investigational Site Chula Vista, California, United States
NCT02548000
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Hospital de Clinicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
- Federal University of Rio Grande do Sul, Physical Education School Porto Alegre, Rio Grande do Sul, Brazil
NCT00300287
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Investigative Sites, Germany
Completed
Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes
NCT00099892
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Guntur, Andhra Pradesh, India
- Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India
- Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India
- Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India
NCT01954771
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Capital Medical University Affiliated Beijing Anzhen Hospital Beijing, Beijing Municipality, China